Evolving Frontline Therapy for Chronic Lymphocytic Leukemia (CLL)
Update: 2025-05-15
Description
Brian T. Hill, MD, PhD, Director of the Lymphoid Malignancies Program at Cleveland Clinic, joins the Cancer Advances Podcast to talk about the latest updates in first-line therapy for chronic lymphocytic leukemia (CLL). During this episode, Dr. Hill explains the shift from traditional chemoimmunotherapy to more precise, targeted treatments, and how customized therapy is transforming patient outcomes.
Comments
In Channel